These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29051061)

  • 21. Nail swelling as a pre-formulation screen for the selection and optimisation of ungual penetration enhancers.
    Khengar RH; Jones SA; Turner RB; Forbes B; Brown MB
    Pharm Res; 2007 Dec; 24(12):2207-12. PubMed ID: 17665289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of different formulations for drug delivery through the nail plate.
    Vejnovic I; Simmler L; Betz G
    Int J Pharm; 2010 Feb; 386(1-2):185-94. PubMed ID: 19941943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ablation of human nail by pulsed lasers.
    Neev J; Nelson JS; Critelli M; McCullough JL; Cheung E; Carrasco WA; Rubenchik AM; Da Silva LB; Perry MD; Stuart BC
    Lasers Surg Med; 1997; 21(2):186-92. PubMed ID: 9261796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug delivery to the nail following topical application.
    Murdan S
    Int J Pharm; 2002 Apr; 236(1-2):1-26. PubMed ID: 11891066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
    Elsayed MM
    J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A platform for predicting and enhancing model drug delivery across the human nail plate.
    Vaka SR; Murthy SN; O'Haver JH; Repka MA
    Drug Dev Ind Pharm; 2011 Jan; 37(1):72-9. PubMed ID: 20545509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iontophoretic drug delivery across the nail.
    Delgado-Charro MB
    Expert Opin Drug Deliv; 2012 Jan; 9(1):91-103. PubMed ID: 22149385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iontophoresis for drug delivery into the nail apparatus: exploring hyponychium as the site of delivery.
    Kushwaha A; Shivakumar HN; Murthy SN
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1678-82. PubMed ID: 26981643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel nail penetration enhancer containing vesicles "nPEVs" for treatment of onychomycosis.
    Bseiso EA; Nasr M; Sammour OA; Abd El Gawad NA
    Drug Deliv; 2016 Oct; 23(8):2813-2819. PubMed ID: 26447337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TranScreen-N: Method for rapid screening of trans-ungual drug delivery enhancers.
    Murthy SN; Vaka SR; Sammeta SM; Nair AB
    J Pharm Sci; 2009 Nov; 98(11):4264-71. PubMed ID: 19363796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of controlled laser microporation on drug transport kinetics into and across the skin.
    Bachhav YG; Summer S; Heinrich A; Bragagna T; Böhler C; Kalia YN
    J Control Release; 2010 Aug; 146(1):31-6. PubMed ID: 20678988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled nail delivery of a novel lipophilic antifungal agent using various modern drug carrier systems as well as in vitro and ex vivo model systems.
    Naumann S; Meyer JP; Kiesow A; Mrestani Y; Wohlrab J; Neubert RH
    J Control Release; 2014 Apr; 180():60-70. PubMed ID: 24560884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.
    Hafeez F; Hui X; Selner M; Rosenthal B; Maibach H
    Drug Dev Ind Pharm; 2014 Jun; 40(6):838-44. PubMed ID: 23600655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Laser-Assisted Trans-Nail Drug Delivery with Optical Coherence Tomography.
    Tsai MT; Tsai TY; Shen SC; Ng CY; Lee YJ; Lee JD; Yang CH
    Sensors (Basel); 2016 Dec; 16(12):. PubMed ID: 27973451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trans-ungual iontophoretic delivery of terbinafine.
    Nair AB; Vaka SR; Sammeta SM; Kim HD; Friden PM; Chakraborty B; Murthy SN
    J Pharm Sci; 2009 May; 98(5):1788-96. PubMed ID: 18781625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pharmaceutics perspective on drug delivery to the nail: recent advances and challenges.
    Delgado-Charro MB
    Ther Deliv; 2015 Jul; 6(7):773-5. PubMed ID: 26228770
    [No Abstract]   [Full Text] [Related]  

  • 37. Overcoming the nail barrier: A systematic investigation of ungual chemical penetration enhancement.
    Brown MB; Khengar RH; Turner RB; Forbes B; Traynor MJ; Evans CR; Jones SA
    Int J Pharm; 2009 Mar; 370(1-2):61-7. PubMed ID: 19071202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Permeation studies of novel terbinafine formulations containing hydrophobins through human nails in vitro.
    Vejnovic I; Huonder C; Betz G
    Int J Pharm; 2010 Sep; 397(1-2):67-76. PubMed ID: 20620203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
    Bhatt V; Pillai R
    J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of ablative laser on in vitro transungual delivery.
    Nguyen HX; Banga AK
    Int J Pharm; 2018 Jun; 544(2):402-414. PubMed ID: 28951347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.